Criteria for the clinical use of Intravenous Immunoglobulin in Australia - Second Edition
Home
Contents
Contents
Foreword
Index of conditions
Executive summary
1. Introduction
2. Production of normal immunoglobulins
3. Intravenous immunoglobulin supply and demand
4. Development and maintenance of the Criteria
5. Conditions for which IVIg has an established therapeutic role
6. Conditions for which IVIg has an emerging therapeutic role
7. Conditions for which IVIg use is in exceptional circumstances only
8. Conditions for which IVIg use is not supported
Acronyms and abbreviations
Glossary of terms
Bibliography
Appendix A: Funding policy statement
Appendix B: National Stewardship Expectations
Appendix C: Development of the
Criteria for the clinical use of IVIg in Australia
(First Edition)
Appendix D: 2010–11 Criteria Review
Appendix E: Alphabetical index of conditions
Index
List of figures
List of tables
List of figures
Figure 1 Plasma sent to CSL Biotherapies Australia for fractionation
Figure 2 IVIg grams issued in Australia
Figure 3 Australian IVIg issued in g/1000 head of population